Fernandez-Carvajal, A., angeli, a., Micheli, L., carta, f., Ferraroni, M., PIRALI, T., . . . Supuran, C. (2023). First-in-Class Dual Hybrid Carbonic Anhydrase Inhibitors and Transient Receptor Potential Vanilloid 1 Agonists Revert Oxaliplatin-Induced Neuropathy.
Citación estilo ChicagoFernandez-Carvajal, Asia, et al. First-in-Class Dual Hybrid Carbonic Anhydrase Inhibitors and Transient Receptor Potential Vanilloid 1 Agonists Revert Oxaliplatin-Induced Neuropathy. 2023.
Cita MLAFernandez-Carvajal, Asia, et al. First-in-Class Dual Hybrid Carbonic Anhydrase Inhibitors and Transient Receptor Potential Vanilloid 1 Agonists Revert Oxaliplatin-Induced Neuropathy. 2023.
Precaución: Estas citas no son 100% exactas.